Application
CRLF3 Antibody (C-term) western blot analysis in NCI-H460 cell line lysates (35ug/lane).This demonstrates the CRLF3 antibody detected the CRLF3 protein (arrow).| Product Name | CRLF3 Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | CRLF3; CREME9; CYTOR4; P48; Cytokine receptor-like factor 3; Cytokine receptor-like molecule 9; Cytokine receptor-related protein 4; Type I cytokine receptor-like factor p48 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | CREME9 CRLM9 CYTOR4 P48 |
|---|---|
| Alternative Names | CRLF3 CREME9 CYTOR4 P48 Cytokine receptor-like factor 3 Cytokine receptor-like molecule 9 Cytokine receptor-related protein 4 Type I cytokine receptor-like factor p48 |
| Molecular Weight(MW) | 49766 Da |
| Function | May play a role in the negative regulation of cell cycle progression |
| Tissue Specificity | Expressed in several embryonic and adult tissues, including adult and fetal brain, liver, spleen and pancreas. Expressed in adult, but not fetal kidney. Expressed in skin and squamous cell carcinoma (SCC) and in several other cancer types. Also detected in lesion actinic keratosis (AK) |
| Cellular Localization | Cytoplasm. Note=The EGFP- and MYC-tagged protein has been shown to be cytoplasmic (PubMed:19427400) |
| Entrez Gene | 51379 |
|---|---|
| Nucleotide Accession | NP_057070.3 |
Application
CRLF3 Antibody (C-term) western blot analysis in NCI-H460 cell line lysates (35ug/lane).This demonstrates the CRLF3 antibody detected the CRLF3 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
